NUTRITION, TREATMENT AND CARDIOVASCULAR RISK MANAGEMENT



Similar documents
Assist. Profesor Dušan Djurić, M.D., PhD Postgraduate Diploma in Pharmaceutical Medicine, School of Medicine, University of Belgrade, Serbia.

Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine

Invitation to Host Academy Event

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011

International Symposium on. Enterococci in Foods. Functional and Safety Aspects. 2nd Announcement and Call for Papers

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

J D R F R E Q U E S T S L E T T E R S O F I N T E N T F O R : B I O M AR K E R S O F P AN C R E A T I C B E T A C E L L S T R E S S AN D H E AL T H

MINISTRY OF PUBLIC HEALTH OF UKRAINE THE NATIONAL UNIVERSITY OF PHARMACY

8 11 December 2011 Alexandria, Egypt

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH

Subject Index. Bariatric surgery, obesity management 134

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

INTERPROFESSIONAL WOUND MANAGEMENT COURSE:

NO More Heart Disease

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

BSc (Hons)/MSc Nutritional Sciences - SC527 (Under Review)

Biogenic Amines 2011

PG Certificate / PG Diploma / MSc in Clinical Pharmacy

Chocolate and Cocoa in Medicine

Among the Top Ranked in the World. International Cooperation. Education

2015 Diabetes Conference Friday, November 6, 2015 Hotel Marshfield, 2700 S. Central Avenue, Marshfield, WI Co sponsored by:

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

2011 Southwest Diabetes Symposium

How To Treat Dyslipidemia

R&D STRATEGY & NATIONAL FUNDING IN SERBIA

Kinesiology Graduate Course Descriptions

GRADUATE PROGRAMS IN HUMAN NUTRITION COURSE DESCRIPTIONS

Detailed Course Descriptions for the Human Nutrition Program

High Blood Pressure. Dr. Rath s Cellular Health Recommendations for Prevention and Adjunct Therapy

Minimally Invasive Cardiac Surgery

Cholesterol made simple!

EXERCISE SCIENCE AND NUTRITION

Listen to your heart: Good Cardiovascular Health for Life

THE LINCOLN INSTITUTE OF HEALTH

Preventive and personalized health care in cardiovascular disease an update

YOUR LAST DIET IDEAL PROTEIN

XXIII AINI Congress Italian Association of Neuroimmunology Milan (Italy) August 22 nd, 2013

Cardiovascular Disease Risk Factors

Human Health Sciences

Stem cells: the diverging goals of regenerative medicine and oncology ROME JULY 1-2, 2010 CALL FOR ABSTRACTS

FOUNDATION KNOWLEDGE AND SKILLS

Dear Colleagues, We are very much looking forward to meeting you this autumn.

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

Discovery Grants Request for Applications

Introduction. Pathogenesis of type 2 diabetes

Include Dietitian Services in Extended Health Care Plan

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

First announcement INTERNATIONAL SCIENTIFIC CONFERENCE

From Concept to a Published Paper - a guide to excellence in Medical Research.

ANTI-AGING REGENERATIVE THE GLOBAL SERIES OF & AESTHETIC MEDICINE CONFERENCES & EXHIBITIONS

A Calorie is a Calorie Or is It? 6 th Biennial Childhood Obesity Conference, June 30, 2011

Effects of macronutrients on insulin resistance and insulin requirements

Curriculum Overview:

Duke Regional Diabetes Symposium 2012

Preventive Telemedicine Challenges in Russia

Version Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Drug Safety of Stem Cells and other Novel Therapeutics

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

PRESIDENTS of the Congress Claudio Allegra (Italy) Pier Luigi Antignani (Italy)

WHO STEPwise approach to chronic disease risk factor surveillance (STEPS)

AST Transplantation and Immunology Research Network (TIRN) 2016 Allied Health Professional Research Grant

Scientific Advances in Pediatrics (Combined with the Etteldorf Symposium)

LIQUID BIOPSY: TRACKING CANCER

Education. Panel. Triglycerides & HDL-C

Masters Learning mode (Форма обучения)

Rural and Remote Mental Health Conference October 2015 Bunbury Regional Entertainment Centre Bunbury, Western Australia

Obtaining Funding in Clinical Research

The Polyphenol Study. Effect of Dietary Polyphenols on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome

Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F.

Master of Science in Nutrition and Wellness Curriculum

Albany Medical College presents. Cardiology. for the Primary Care Practitioner. Saturday, November 7, 2009

J D R F R E Q U E S T S E X P R E S S I O N S O F I N T E R E S T F O R : C O M B I N AT I O N T H E R AP I E S I N T Y P E 1 D I A B E T E S

YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels

The Canadian Association of Cardiac

CLINICAL NUTRITION (Curriculum Code GECNU002) 40 credits

Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search

Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases

9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium

SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN

Neal Rouzier responds to the JAMA article on Men and Testosterone

Intra- and interorgan communication of the cardiovascular system

Guidelines for the management of hypertension in patients with diabetes mellitus

Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc.

Coronary CTA in the Emergency Department A Hands-on Workshop

Common Outcomes/Competencies for the CCN Nursing Web Page

Corporate Medical Policy

CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE

Neurological Disorders Summit

Transcription:

SERBIAN ASSOCIATION FOR ARTERIOSCLEROSIS, THROMBOSIS AND VASCULAR BIOLOGY RESEARCH & THE SERBIAN PHYSIOLOGICAL SOCIETY are pleased to announce A SCIENTIFIC CONFERENCE WITH INTERNATIONAL PARTICIPATION WITH 12 HOURS OF EUROPEAN EXTERNAL CME CREDITS (ECMEC) BY EUROPEAN ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (EACCME) ON NUTRITION, TREATMENT AND CARDIOVASCULAR RISK MANAGEMENT UNDER THE AUSPICES OF THE INTERNATIONAL ACADEMY OF CARDIOVASCULAR SCIENCES (IACS) AND THE INTERNATIONAL ATHEROSCLEROSIS SOCIETY (IAS) MAY 24-27, 2007 HOTEL PARK, NOVI SAD, SERBIA ANNOUNCEMENT & CALL FOR ABSTRACTS AND PAPERS www.physiology.org.yu/eng/htm/konf2007/announcement.pdf

FOREWORD For the last few years, the Serbian Physiological Society, with the special involvement of its Section for Arteriosclerosis, Thrombosis and Vascular Biology Research has developed a series of internationally recognized conferences. The First Congress of Physiological Sciences with international participation (November 9-12, 2005), as well as the Satellite Symposium of the XIV International Symposium on Atherosclerosis (June 15-16, 2006) held at the Military Medical Academy in Belgrade are two excellent recent examples of such activities. These meetings attracted a worldwide scientific audience and was supported by the International Academy of Cardiovascular Sciences (IACS), the International Atherosclerosis Society (IAS), the Federation of European Physiological Societies (FEPS), the International Union of Physiological Sciences (IUPS), and the International Society for Pathophysiology (ISP). One of the first thematic conferences that we organized was held in the territory of Vojvodina (Zrenjanin, November 7-9, 2003). Because of its importance to our country, it was decided that a similar event should be organized four years later in beautiful Novi Sad. A primary objective of the meeting is to improve the health and medical education of our citizens so we have intentionally connected biomedical science and practice in the scientific program for this conference. The focus of the meeting is NUTRITION, TREATMENT AND CARDIOVASCULAR RISK MANAGEMENT which presents a unique opportunity to provide the latest information in the fight against the most wide spread disease in the world today - arteriosclerosis and all of its consequences. In our country, mortality caused by arteriosclerosis has reached the astonishing rate of more than 60%. Improper nutrition and obesity play important roles in the pathogenesis of this severe disease and its direct consequences. With these sobering facts in mind, justification for such a meeting is clear. This meeting will provide a unique opportunity to bring together medical researchers and clinical practitioners as well as scientists in other related disciplines like food production and examination. This multidisciplinary focus of the meeting will also fulfill standards in this regard that will soon be required by the European Union in the near future. The strong support given by our eminent experts in this field locally as well as that shown by our scientific friends from abroad give every indication that this meeting will be an unqualified success! Welcome to Novi Sad! Vladimir Jakovljević and Dragan Djurić CO- CHAIRMEN PROGRAM/ORGANIZING COMMITTEE

TOPICS 1. Nutrigenomics and genetic epidemiology of cardiovascular diseases 2. Coronary heart disease, stroke and nutrition 3. Diabetes and nutrition 4. Hypertension and nutrition 5. Lipids, dyslipidemias and lipid metabolism 6. Obesity, metabolic syndrome, weight reduction and nutrition 7. Menopause, cardiovascular risk and nutrition 8. Aging, cardiovascular risk and nutrition 9. Precursors of atherosclerosis: childhood obesity and nutrition 10. Optimal atherosclerosis managament 11. Cardiovascular risk factors and epidemiology of cardiovascular diseases 12. Biomarkers for risk determination: novel risk factors 13. Biomarkers for risk determination: novel laboratory approaches 14. Endothelial dysfunction and atherosclerosis: mechanisms and therapeutical intervention 15. New treatment paradigms: intensive cholesterol lowering therapy 16. Pharmacology of arterial disease: HDL-targeted therapies 17. Phytosterol-based functional foods: new tools in cardiovascular disease prevention 18. Dietary approaches for atherosclerosis prevention: vegetables, fruits anddietary fibre 19. Edible plants and optimized nutrition 20. Role of micronutrients (vitamins & trace elements) in cardiovascular health and disease 21. Water, electrolyte homeostasis and parenteral nutrition 22. Functional foods, herbal remedies and dietary supplements 23. Drug and nutraceutical discovery process: opportunities for health foods and pharmaceutical industry 24. Food products and technologies for cardiovascular health 25. Guidelines for global cardiovascular risk assessment 26. Global intervention at the population level 27. Basic research and animal models for the discovery of new cardiovascular therapies 28. Physical activity, exercise and cardiovascular health 29. Immunity, nutrition and cardiovascular health 30. Smoking cessation for improving cardiorespiratory health 31. Role of dietary fat in cardiovascular health and disease 32. Reduction of sodium intake in the prevention of hypertension 33. Herbal/food-drug interactions and their clinical relevance 34. Others

CO- CHAIRMEN PROGRAM/ORGANIZING COMMITTEE Jakovljević V (Kragujevac), Djurić D (Belgrade) CONFERENCE HONORARY CO-CHAIRMEN Dhalla NS (Winnipeg, Canada), Pierce GN (Winnipeg, Canada), Sirtori C (Milan, Italy) ADVISORY BOARD* Buttar H, Ottawa, Canada Lepšanović L, Novi Sad CONFERENCE DIRECTOR Berkowitz I, MBA Harvard, Winnipeg, Canada PRELIMINARY PROGRAM COMMITTEE AND CME FACULTY * Alavantić D, Vinča, Belgrade Andjelković Z, Belgrade Arsenijević N, Kragujevac Babić M, Belgrade Blagojević D, Belgrade Bojanić V, Niš Bojanić Z, Niš Čolić M, Belgrade Damjanov V, Kragujevac/Belgrade Djerić M, Novi Sad Djokić I, Leeds, UK Djordjević M, Belgrade Dobrić S, Belgrade Dragojević-Simić V, Belgrade Filipović D, Novi Sad Gojković-Bukarica Lj, Belgrade Ivetić V, Novi Sad Ivković-Lazar T, Novi Sad Janković S, Kragujevac Jokanović M, Belgrade Jovanovski Z, Belgrade Jovović Dj, Belgrade Jurišić V, Kragujevac Kašanin J, Belgrade Kažić T, Belgrade Kocić R, Niš Kojić Z, Belgrade Korać B, Belgrade Lažetić B, Novi Sad Lepšanović Lj, Novi Sad Maksimović Ž, Belgrade Maličević Ž, Belgrade Mazić S, Belgrade Medić-Ristić D, Belgrade Mijailović Z, Belgrade Milanović Z, Priština/Kosovska Mitrovica Milenković P, Belgrade Miljuš D, Belgrade Milošević V, Belgrade Milovanović D, Kragujevac Mitrović D, Belgrade Nešić M, Niš Nešković A, Belgrade Novaković B, Novi Sad Obradović S, Belgrade Pajović S, Vinča, Belgrade Pantelinac P, Novi Sad Pantić V, Belgrade Pavlović K, Novi Sad Pavlović M, Subotica/Belgrade Radak Dj, Belgrade Radaković S, Belgrade Radenković M, Niš Radenović L, Belgrade Radjen G, Belgrade Radjen S, Belgrade Radosavljević T, Belgrade Radovanović D, Niš Rosić G, Kragujevac Rosić M, Kragujevac Saičić Z, Belgrade Savić M, Belgrade Šćepanović Lj, Belgrade Šikić B, Belgrade Škorić D, Novi Sad Spasić M, Belgrade Stanojević-Mihailović N, Belgrade Stanojlović O, Belgrade Starčević V, Belgrade Stevanović D, Belgrade Stojanović T, Kragujevac Stojiljković M, Belgrade Stojković M, Belgrade Stojšić Dj, Novi Sad Stokić E, Novi Sad Suzić J, Belgrade Suzić S, Belgrade Tarabar D, Belgrade Tasić N, Belgrade Todorović V, Belgrade Velimirović D, Belgrade Vitošević B, Priština/Kosovska Mitrovica Vitošević Z, Priština/Kosovska Mitrovica Vranić I, Belgrade Žigon N, Belgrade Žikić R, Kragujevac Živković M, Belgrade *Surnames are given in alphabetical order

CONFIRMED LECTURES Naranjan S. Dhalla (Winnipeg, Canada): Role of Renin-Angiotensin System in Cardiac Dysfunction in Chronic Diabetes Grant N. Pierce (Winnipeg, Canada): The use of flaxseed as a dietary intervention to influence cardiovascular disease Ivan Berkowitz (MBA Harvard, Winnipeg, Canada): Promotion of Heart Health Harpal S. Buttar (Ottawa, Canada): Drug-Herbal/Food Interactions: Mechanisms of Interactions and Their Clinical Implications Harpal S. Buttar (Ottawa, Canada): Healing Power of the Herbal & Ayurvedic Medicines Dragan Djurić (Belgrade): Homocysteine and Folic Acid: From Risk Marker to Cardiovascular Prevention Vladimir Jakovljević (Kragujevac): Oxidative stress, Vitamin C and Cardiovascular Diseases Mirko Rosić (Kragujevac): The transport and biomechanical preferences of cardiovascular system in the presence and absance of L-arginine. L-arginine supplementation? Tatjana Ivković-Lazar (Novi Sad): Specifity of the lipid metabolism in obesity Aleksandra Jovelić (Sremska Kamenica/Novi Sad): Pharmacology of arterial disease: HDLtargeted therapies Zorica Jovanovski, Nadja Vasiljević (Belgrade): Nutritional status in elderly and cardiovascular diseases Jelena Kašanin, Vladimir Jorga and Sonja Radaković (Belgrade): The influence of moderate exercise on water-electrolyte (dis)balance in school children Sonja Radaković (MMA, Belgrade): The influence of dietary factors on expression and function of CYP450: Possible role in pathogenesis and prevention of cardiovascular diseases Slavica Radjen (MMA, Belgrade): Intima/media thickness as a risk factor for cardiovascular diseases Goran Radjen (MMA, Belgrade): Atherosclerosis as a inflammatory disease? Key role of HDL Branka Djurović (MMA, Belgrade): Environmental radioactive contamination as a risk factors for cardiovascular disease Jelena Marić (IMR, Belgrade): Insulin resistency in neurodegenerative disorders Pavle Pantelinac (Novi Sad): Nutrition and its importance in diabetes treatment Budimka Novaković (Novi Sad): Obesity, metabolic syndrome, weight reduction and nutrition Tomislav Stojanović (Kragujevac): Lipid profile in subclinical hypothyreosis VK Vijayan (New Delhi, India): Health benefits of smoking cessation with special refernce to cardiorespiratory health Maja Šoštarić (Ljubljana, Slovenia): Cardiac preconditioning and inhalational anesthetics Katica Pavlović (Sremska Kamenica/Novi Sad): Hypertension and nutrition Dragan Škorić, Siniša Jocić, Zvonimir Sakač, Nada Lečić, Etelka Dimić (Novi Sad): Genetic possibilities for altering sunflower oil quality: a new perspectives in human nutrition Ljilja Torović (Novi Sad): Functional foods, herbal remedies and dietary supplements Ljiljana Lepšanovič, Anamarija Mandić and Lazar Lepšanović (Novi Sad): The possibilities and importance of calculated atherogenic index of food products George Chaldakov, Anton Tonchev, Marco Fiore, Gorana Rancic, Dimiter Dimitrov, Roiyha Pancheva, Luigi Aloe (Varna, Bulgaria): Metabotrophic factors and cardiometabolic disease Zoran Miloradović, Nevena Mihailović-Stanojević, Djurdjica Jovović, Jelica Grujić- Milanović and Vladimir Jakovljević (IMR, Belgrade): Effects of Long Term Losartan and L- arginine treatment on haemodznamics and oxidative status in spontaneously hypertensive rats

Vladimir Jurišić (Kragujevac, Serbia): The effects of GMCSF on growth and maintaince of haematological tumor cells Darko Stevanović, Dejan Nešić, Verica Milošević, Dragan Micić, Vesna Starčević (Belgrade, Serbia): Ghrelin and energy balance CALL FOR ABSTRACTS The Program Committee welcomes the submission of original contributions for oral and poster presentations at the Conference. ON-LINE ABSTRACT SUBMISSION On-line submission of Abstracts is encouraged by the Program Committee. Scientific contributions should be according to the Topics of the Conference. Abstracts must be written in English. Please note that abstracts written in English language that is of poor quality will be rejected. PLEASE, SPECIFY THE PREFERENCE OF YOUR PRESENTATION (oral or poster). Accepted abstracts will be scheduled for the type of presentations by the Program Committee. IMPORTANT NOTICE THE DEADLINE FOR ABSTRACT SUBMISSION IS MARCH 15 TH, 2007. Late abstracts will NOT be accepted. ABSTRACTS MUST BE SENT ONLY TO THE E-MAIL ADDRESS OF THE PROGRAM COMMITTEE SECRETARIAT drvladakg@yahoo.com. Transmission of the abstracts via fax, sending floppy discs and CD-s by standard mail is not acceptable. THE NUMBER OF ABSTRACTS SUBMITTED IS NOT LIMITED. Only abstracts accompanied by the payment of the registration fee will be considered for inclusion in the Final Program and for publication in the Abstract Book.

INSTRUCTIONS FOR AUTHORS 1) Abstracts should contain a short TITLE; a list of AUTHOR(S); the INSTITUTION(S) (Italic) where the investigation was performed and the TEXT. 2) The title should be written in capital and bold letters. Underline the presenting author. 3) Abstracts should state the study s objective, briefly describe the MATERIALS AND METHOD used, summarize the RESULTS obtained and state the CONCLUSIONS. 4) The recommended font is Times New Roman and font size 12. Kindly set the language to English. 5) Type the entire abstract single-spaced without margins at the top of sides. 6) Abstracts should contain no more then 250 words. Abstracts received after the deadline and abstracts not completed according to the instructions will not be accepted. EXAMPLE: THE EFFECTS OF NITRIC OXIDE SYNTHASE- OR LIPOXYGENASE INHIBITION ON CORONARY FLOW AND NITRITE OUTFLOW IN ISOLATED RAT HEART Jakovljevic V 1 and Djuric D 2 1 Department of Physiology, Faculty of Medicine, University of Kragujevac; 2 Institute of Medical Physiology, University School of Medicine, Belgrade The aim of this study was to assess the changes of coronary flow and nitrite outflow under inhibition of nitric oxide synthase by L-NAME or lipoxygenase induced by nordihydroguaiaretic (NDGA, LOX-inhibition) acid in isolated rat heart. The hearts of male Wistar albino rats (n=18, age 8 weeks, body mass 180-200 g) were retrograde perfused according to the Langendorff technique at gradually increased constant perfusion pressure conditions (CPP, 40-120 cm H 2 O) which induced flow-dependent NO release (nitrite outflow). The experiments were performed during control conditions, in the presence of nitric oxide synthesis inhibitor L-NAME (30 μm) or nonspecific lipoxygenase inhibitor (NDGA, 0.1 mm) which were administered separately or in combination. Coronary flow (CF) varied in autoregulatory range from 4.12 ± 0.26 ml/min/g wt at 50 cm H 2 O to 5.22 ± 0.26 ml/min/g wt at 90 cm H 2 O. In autoregulatory range nitrite outflow varied from 2.05 ± 0.17 nmol/min/g wt at 50 cm H 2 O to 2.52 ± 0.21 nmol/min/g wt at 90 cm H 2 O and was strictly parallel with CPP-CF (coronary perfusion pressure/coronary flow curve). The autoregulatory range of CF was significantly extended (40 100 cm H 2 O, 2.22 ± 0.12 ml/min/g wt and 2.90 ± 0.25 ml/min/g wt, respectively) under the influence of L-NAME. Hemodynamic effects were accompanied...

NOTIFICATION OF ACCEPTANCE Authors will be informed of their abstract acceptance (or rejection) and the date of presentation not later then April 5 th. For this notification, the correct mailing address including phone, fax number and e-mail address is essential. Please carefully include your e-mail address with your abstract submission. The registered author is responsible for informing all authors of the status of the abstract. PUBLICATION OF ABSTRACTS AND FULL-LENGTH PAPERS Accepted abstracts will be published in the Abstract Book which will be provided upon registration to all delegates attending the Conference. Certain full-length papers (upon invitation only) will be invited for publication in journals currently found in Current Contents or Index Medicus. POSTER INSTRUCTIONS Poster size should be 120 (height) cm x 80 (width) cm. Poster figures should be designed to be viewed from a distance and the authors should use clear, visible graphics and large text fonts. Material for mounting posters will be provided in the poster area. Authors are requested to be present by their posters during the poster session for which their poster has been scheduled. AUDIOVISUAL FACILITIES For the oral presentations, video projections will be available in each conference room. Presentations should be prepared in Power Point (*.ppt file). For special audiovisaul facilities, please make a special request well in advance of the meeting to the Program Secretariat (drvladakg@yahoo.com). REGISTRATION FEE Before May 1 st After May 1 st On site MEMBERS OF SERBIAN PHYSIOLOGICAL SOCIETY 50 80 100 OTHER PARTICIPANTS 80 100 120 STUDENTS* *Certificate required FREE NOTICE: For attendees from abroad payment in Euros to account which will be provided upon request by e-mail. For attendees from Serbia, payment should be (in CSD) provided on a bank account of Društvo fiziologa Republike Srbije N o 205-40932-94, Komercijalna banka a.d, Belgrade.

Full registration fee includes admission to all scientific sessions, the opening ceremony, the welcome reception, the Abstract book and a special issue of an indexed journal. The Gala dinner is not included in the registration fee and would be provided at an additional cost. Application/accommodation/contact The application form should be legibly completed and sent no later than May 1st to the e- mail address of the Program/Organizing Committee (drvladakg@yahoo.com). Hotel accommodation and arrival/departure service will be reserved in different price categories in Novi Sad at special rates. For making hotel reservation at special rates, please contact tanja_alexa@yahoo.com. Confirmation will be sent upon receipt of payment. In order to receive an e-mail confirmation, please indicate your e-mail address. Social program The social program will include convival (welcome reception, cocktail) and cultural (city tours, monasteries tour, visit to museums, etc) events. Exciting social events will be offered (joint dinner with multinational music, Danube tour, visit of Museums, etc.). For more details, plese contact tanja_alexa@yahoo.com Cancellation and refunds Notification of cancellation should be sent in writting to the Program/Organizing Committee. If cancellation is received before May 5th 2006, 70 % of the total amount will be refunded to the participant. We regret that no refunds can be provided for cancellations received on or after that date. Please note that for administartive reasons, refunds will be provided after the Conference. SUMMARY OF THE IMPORTANT INFORMATION The first announcement: November 2006 The second announcement: January 2007 Abstract submission deadline: March 15th, 2007 Symposium date: May 24-27, 2007 Satellite Meeting Venue: Hotel Park, Novi Sad, Serbia FOR OTHER INQUIRES PLEASE CONTACT: Dr. Vladimir Lj. Jakovljevic, MD, PhD Department of Medical Physiology Faculty of Medicine, University of Kragujevac Svetozara Markovica 69, P.O.B. 124 34000 Kragujevac, Serbia Phone: +381 34 342 944, Fax: + 381 34 306 800/ext 112 E-mail: drvladakg@yahoo.com

APPLICATION FORM NUTRITION, TREATMENT AND CARDIOVASCULAR RISK MANAGEMENT May 24-27, 2007, Hotel Park Novi Sad, Serbia FIRST NAME AND SURNAME PROFESSION/TITLE INSTITUTION ADDRESS COUNTRY Phone Fax E-mail TITLE OF PRESENTATION SCIENTIFIC TOPIC PRESENTATION PREFERENCE ORAL POSTER EITHER Date: Signature: *Please, fill this form and send it to the Program/Organizing Committee e-mail address drvladakg@yahoo.com till May 1st, 2007. www.physiology.org.yu/eng/htm/konf2007/announcement.pdf